Table 323 BMI and colorectal cancer risk. Main characteristics of studies excluded from the CUP SLR dose-response meta-analysis Author, Year, Study name, Study size Case Exposure RR (95%CI) Adjustment Reasons for WCRF Code, Outcome Comparison characteristics Follow-up ascertainment assessment Ptrend factors exclusion Country (years) per 1 1.12 (1.06-1.17) 1 WHI, 904/ Incidence, Prospective Self-report 144 701 high risk vs low colorectal cancer 1.12 (1.02-1.24) Heo, 2015 12 Cohort, years verified by Height and risk kg/m2 COL41057 Age: 50-79 medical record weight were per 1 1.12 (1.06-1.18) USA years, and pathology measured Incidence, colon 1 W, 516/ report high risk vs low cancer 1.18 (1.05-1.33) postmenopausal risk kg/m2
Table 323 BMI and colorectal cancer risk. Main characteristics of studies excluded from the CUP SLR dose-response meta-analysis Author, Year, WCRF Code, Country Study name, characteristics Study size Follow-up (years) Case ascertainment Exposure assessment Outcome Comparison RR (95%CI) Ptrend Adjustment factors Reasons for exclusion Heo, 2015 COL41057 USA WHI, Prospective Cohort, Age: 50-79 years, W, postmenopausal 1 904/ 144 701 12 years Self-report verified by medical record and pathology report Height and weight were measured Incidence, colorectal cancer per 1 1.12 (1.06-1.17) high risk vs low risk kg/m2 1.12 (1.02-1.24) 1 516/ Incidence, colon cancer per 1 1.12 (1.06-1.18) high risk vs low risk kg/m2 1.18 (1.05-1.33)
CUP_colorectal_SLR_2016_RO.docx